ZA988052B - Transdermal therapeutic system comprising the active substance scopolamine base - Google Patents

Transdermal therapeutic system comprising the active substance scopolamine base

Info

Publication number
ZA988052B
ZA988052B ZA988052A ZA988052A ZA988052B ZA 988052 B ZA988052 B ZA 988052B ZA 988052 A ZA988052 A ZA 988052A ZA 988052 A ZA988052 A ZA 988052A ZA 988052 B ZA988052 B ZA 988052B
Authority
ZA
South Africa
Prior art keywords
active substance
transdermal therapeutic
layer
therapeutic system
scopolamine base
Prior art date
Application number
ZA988052A
Other languages
English (en)
Inventor
Walter Mueller
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of ZA988052B publication Critical patent/ZA988052B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
ZA988052A 1997-09-04 1998-09-03 Transdermal therapeutic system comprising the active substance scopolamine base ZA988052B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19738643A DE19738643C2 (de) 1997-09-04 1997-09-04 Transdermales therapeutisches System mit dem Wirkstoff Scopolaminbase und Verfahren zu seiner Herstellung

Publications (1)

Publication Number Publication Date
ZA988052B true ZA988052B (en) 1999-03-05

Family

ID=7841162

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA988052A ZA988052B (en) 1997-09-04 1998-09-03 Transdermal therapeutic system comprising the active substance scopolamine base

Country Status (22)

Country Link
US (1) US6537571B1 (fr)
EP (1) EP1011674B1 (fr)
JP (1) JP3834202B2 (fr)
KR (1) KR100549846B1 (fr)
AT (1) ATE214606T1 (fr)
AU (1) AU738009B2 (fr)
CA (1) CA2300339C (fr)
DE (2) DE19738643C2 (fr)
DK (1) DK1011674T3 (fr)
ES (1) ES2174492T3 (fr)
HK (1) HK1032194A1 (fr)
HU (1) HUP0003480A3 (fr)
ID (1) ID24266A (fr)
IL (1) IL134418A (fr)
NO (1) NO20000894L (fr)
NZ (1) NZ502873A (fr)
PL (1) PL339226A1 (fr)
PT (1) PT1011674E (fr)
SK (1) SK3052000A3 (fr)
TR (1) TR200000407T2 (fr)
WO (1) WO1999011265A1 (fr)
ZA (1) ZA988052B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050013957A1 (en) * 2003-07-15 2005-01-20 Boris Leschinsky Disposable medical article with multiple adhesives for skin attachment
DE102004020463A1 (de) * 2004-04-26 2005-11-10 Grünenthal GmbH Wirkstoffabgabesystem aus einem wirkstoffhaltigen Pflaster und mindestens einem Wirkstoffabgaberegulierungsmittel
DE102004044578A1 (de) * 2004-09-13 2006-03-30 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit einer Haftschicht, Verfahren zum Silikonisieren einer Rückschicht des Systems und Verwendung der Rückschicht
US20070010550A1 (en) * 2005-07-08 2007-01-11 The Board Of Regents Of The University Of Texas Scopolamine to Reduce or Eliminate Hot Flashes, Night Sweats, and Insomnia
RU2008138595A (ru) * 2006-02-27 2010-04-10 Ноувен Фамэсьютикэлз, Инк. (US) Гибкая ограниченная система для трансдермального введения скополамина, способ ее изготовления и способ трансдермальной доставки скополамина с ее помощью
DE102006054732B4 (de) * 2006-11-21 2010-12-30 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit Ionenpaar-Mikroreservoiren
KR101572721B1 (ko) 2013-10-14 2015-11-27 주식회사 엘지생활건강 히오신을 유효 성분으로 함유하는 피부 건조증 또는 피부 장벽 기능 개선용 조성물
JP2018514511A (ja) * 2015-04-14 2018-06-07 アトッサ ジェネティックス インク． 乳房障害とエストロゲン関連障害の処置のための組成物と方法
CN110809466A (zh) * 2017-06-26 2020-02-18 罗曼治疗系统股份公司 含东莨菪碱和硅氧烷丙烯酸杂化聚合物的经皮治疗系统
DE102018118507A1 (de) * 2018-07-31 2020-02-06 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Abgabe von Scopolamin ohne Membran

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US35474A (en) * 1862-06-03 Improved rocket-harpoon
US3797494A (en) 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3903880A (en) * 1972-08-17 1975-09-09 Alza Corp Intrauterine device for managing the reproductive process
US4573996A (en) * 1984-01-03 1986-03-04 Jonergin, Inc. Device for the administration of an active agent to the skin or mucosa
US4655767A (en) * 1984-10-29 1987-04-07 Dow Corning Corporation Transdermal drug delivery devices with amine-resistant silicone adhesives
US4832953A (en) 1987-08-13 1989-05-23 Alza Corporation Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
DE3908431A1 (de) * 1989-03-15 1990-09-27 Lohmann Therapie Syst Lts Transdermales system mit gestufter wirkstoffabgabe und verwendung fuer die lokale oder systemische wirkstoffverabreichung
KR950703997A (ko) 1993-09-30 1995-11-17 야마구치 아쓰무 경피 흡수 제제(Percutaneously absorbable preparation)
DE4438989C2 (de) * 1994-09-16 1999-02-25 Lohmann Therapie Syst Lts Scopolaminpflaster
US5714162A (en) * 1994-09-16 1998-02-03 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Scopolamine patch
AU1120097A (en) * 1995-12-01 1997-06-27 Alza Corporation Improved method for preventing crystal formation in a dispersion of a liquid in a matrix

Also Published As

Publication number Publication date
SK3052000A3 (en) 2000-12-11
HUP0003480A2 (hu) 2001-02-28
ID24266A (id) 2000-07-13
NO20000894D0 (no) 2000-02-23
JP3834202B2 (ja) 2006-10-18
NZ502873A (en) 2001-07-27
TR200000407T2 (tr) 2000-08-21
EP1011674B1 (fr) 2002-03-20
IL134418A0 (en) 2001-04-30
KR100549846B1 (ko) 2006-02-06
US6537571B1 (en) 2003-03-25
EP1011674A1 (fr) 2000-06-28
CA2300339C (fr) 2007-07-17
AU738009B2 (en) 2001-09-06
AU9343498A (en) 1999-03-22
JP2001514226A (ja) 2001-09-11
NO20000894L (no) 2000-02-23
ES2174492T3 (es) 2002-11-01
HUP0003480A3 (en) 2001-03-28
WO1999011265A1 (fr) 1999-03-11
PL339226A1 (en) 2000-12-04
DE59803454D1 (de) 2002-04-25
KR20010023647A (ko) 2001-03-26
IL134418A (en) 2004-02-19
CA2300339A1 (fr) 1999-03-11
PT1011674E (pt) 2002-08-30
DE19738643C2 (de) 2001-10-04
DK1011674T3 (da) 2002-07-08
HK1032194A1 (en) 2001-07-13
ATE214606T1 (de) 2002-04-15
DE19738643A1 (de) 1999-03-11

Similar Documents

Publication Publication Date Title
CA2302601A1 (fr) Systeme therapeutique transdermique a couche-reservoir autocollante et a couche envers a elasticite unidirectionnelle
IE59729B1 (en) Therapeutic system, process for its production and its use
JPS6468314A (en) Transdermal drug administration system containing two kind of permeation accelerators
CA2153572A1 (fr) Systeme therapeutique pour administration transdermique, avec la galanthamine comme principe actif
MY132338A (en) Estradiol-containing patch
HK1032194A1 (en) Transdermal therapeutic system containing the active substance scopolamine base
CA2338859A1 (fr) Emplatre contenant de l'estradiol pour l'administration transdermique d'hormones
CA2335582A1 (fr) Systeme therapeutique transdermique, contenant des hormones et des inhibiteurs de cristallisation
CA2490573A1 (fr) Systeme d'administration transdermique ameliore
CA2403949A1 (fr) Systeme therapeutique transdermique pour administrer du lerisetron
AU2001230193A1 (en) Transdermal therapeutic system for the administration of zaleplon
MY110391A (en) Nitroglycerin-containing patch, a process for the production and the use thereof